Coordinated care trial for heart attack with shock
Part of Heart & circulation clinical trials.
This trial tests a team-based care approach for people having a severe heart attack that leads to cardiogenic shock (when the heart can't pump enough blood). The goal is to see if a coordinated team of specialists can improve survival and recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You had a heart attack (acute myocardial infarction) within the last 12 hours.
- Your heart is pumping so weakly that your blood pressure is dangerously low (cardiogenic shock).
- You are cared for at one of the study hospitals and agree to the team-based treatment plan.
- You or your legal guardian can sign a consent form and complete follow-up appointments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment plan for people having a severe heart attack that causes cardiogenic shock, where the heart can't pump enough blood. The study uses a special heart pump to support patients during an emergency procedure to open blocked arteries.
This trial is testing different approaches (medications and mechanical support) to help people with acute heart failure and cardiogenic shock (a sudden drop in the heart's pumping ability). It looks at how well these treatments work in a network of hospitals to improve outcomes.
This study tracks how well people with cardiogenic shock (a life-threatening drop in blood flow after a heart attack or heart failure worsening) do when treated with modern support devices and medicines.
This trial tests whether using a temporary heart pump plus close monitoring improves recovery in people with severe heart failure after a heart attack, compared to standard care.
This registry collects information from patients admitted to the hospital with cardiogenic shock—a serious condition where the heart cannot pump enough blood to the body. Doctors will gather data to better understand what happens to these patients and how to improve their care.
This trial studies how to identify different types of “cardiogenic shock,” a serious drop in heart blood flow. It aims to use detailed patient information to guide care and possibly lower the chance of dangerous outcomes.
Hear when a new Acute Myocardial Infarction Complicated With Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.